Sophia Genetics SA (SOPH) — Financial Flexibility Index
Sophia Genetics SA (SOPH) has a Financial Flexibility Index of -0.08x as of September 2025. Free cash flow of $-8.69 Million (operating CF $-8.79 Million minus capex $106.00K) represents 0% of total liabilities ($102.77 Million). Also explore net asset momentum of Sophia Genetics SA to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sophia Genetics SA Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Sophia Genetics SA across 6 annual periods. Check Sophia Genetics SA PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sophia Genetics SA (2019–2024)
Year-by-year free cash flow to debt coverage for Sophia Genetics SA. For the full company profile including market capitalisation, see SOPH company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.59x | $-34.65 Million | $-42.82 Million | $58.82 Million | ▲ +18.1% |
| 2023 | -0.72x | $-39.35 Million | $-48.58 Million | $54.71 Million | ▲ +47.4% |
| 2022 | -1.37x | $-59.71 Million | $-70.09 Million | $43.71 Million | ▼ -19.3% |
| 2021 | -1.15x | $-51.27 Million | $-57.94 Million | $44.77 Million | ▼ -26.9% |
| 2020 | -0.90x | $-28.53 Million | $-31.73 Million | $31.61 Million | ▲ +7.4% |
| 2019 | -0.97x | $-28.65 Million | $-31.68 Million | $29.40 Million | — |